Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
about
A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancyReview of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationThe influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic reviewEfficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studiesPharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidenceModelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesOptimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malariaPharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malariaOpposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies.Treatment regimens for pregnant women with falciparum malaria.Lopinavir/ritonavir enhanced the antimalarial activity of amodiaquine and artesunate in a mouse model of Plasmodium berghei.Standby emergency treatment of malaria in travelers: experience to date and new developments.Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
P2860
Q17485688-D6BD0CA9-AC0B-4C51-ACEF-4D7479B9C054Q21034080-2CA45833-F9C6-43A9-AE61-93E391CB8E49Q28079877-E1EEB502-E69D-46DB-8078-4E34F9169AAAQ28535686-57362BA9-6F7A-4288-AD41-963F3F46ADF9Q34034413-4C522A03-FD37-4665-ADE9-79BB6A11FA9CQ34433106-027177FB-E78E-4987-BDBD-66DD023DFDD2Q34456393-41CE0C29-37A1-4D39-914F-60AFA9DA6AB7Q34953705-915285EB-BF73-42DA-A832-22DDBAFD5881Q35163623-C5342FBC-3D2B-44D0-BD44-42E065426F82Q35598379-24CB59AA-393F-44B1-96EB-7AC2A9674667Q35746240-11503CC8-D17D-4AE6-B145-03DFE68BA6ACQ36017416-3E368A91-C28E-48A3-A8B2-175B09F88AE7Q36080121-D75D0B5A-CA42-4F75-A528-3E70A2FE907CQ36125445-C83E39C1-CADB-4982-8A13-64860D59EEAEQ37575742-A2147E04-C8FC-4052-8104-2A397DA79360Q37979631-5315B6A7-91EB-4D84-B123-66FD142D426DQ38051400-C54BC943-2D4A-4CAC-A05A-475914ED6952Q38065917-D2757019-635A-4F90-882D-0BC8EA39B575Q38870452-0921032B-2A86-4E75-9A1A-82482C16A5E9Q40782783-486D4467-9EE8-45D4-9B2B-B03A8DFF268DQ41929207-0027CF54-33A2-4436-A53E-988B6EA6B629Q44872854-9B73F5EA-E7D2-4042-9E47-2FE539011305
P2860
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Population pharmacokinetics of ...... n-pregnant women with malaria.
@ast
Population pharmacokinetics of ...... n-pregnant women with malaria.
@en
Population pharmacokinetics of ...... n-pregnant women with malaria.
@nl
type
label
Population pharmacokinetics of ...... n-pregnant women with malaria.
@ast
Population pharmacokinetics of ...... n-pregnant women with malaria.
@en
Population pharmacokinetics of ...... n-pregnant women with malaria.
@nl
prefLabel
Population pharmacokinetics of ...... n-pregnant women with malaria.
@ast
Population pharmacokinetics of ...... n-pregnant women with malaria.
@en
Population pharmacokinetics of ...... n-pregnant women with malaria.
@nl
P2093
P2860
P921
P356
P1433
P1476
Population pharmacokinetics of ...... n-pregnant women with malaria.
@en
P2093
Antoinette K Tshefu
Carrie A Morris
David Wesche
Edmund Capparelli
Jennifer Hemingway-Foday
Joseph Atibu
Linda Wright
Macaya Douoguih
Marie A Onyamboko
P2860
P2888
P356
10.1186/1475-2875-10-114
P577
2011-05-08T00:00:00Z
P5875
P6179
1004878478